doi: 10.1111/dom.13827, 103
who demonstrated the presence of GHS-R1a in L-cells in murine ileum (31)
Its hard to tell exactly what is happening from this dataset, so we need follow-up studies to help us understand whether the differences seen here hold up in randomized trials. It is unclear how much if any of the benefits observed among GLP-1 users in this study and prior investigations are due to an antitumor effect, but Fuemmeler outlined three potential pathways
NICE guidelines (NG28) support the use of GLP-1 receptor agonists for type 2 diabetes when glycaemic targets are not achieved with other therapies, and for weight management in specific circumstances (TA875 for Wegovy, TA664 for Saxenda)
Additionally, these medications are covered for the treatment of childhood obesity under Medicaids Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit
All lysates underwent differential centrifugation at 4 C for 1500 g (3 min), 3500 g (8 min), and 17,000 g (1 min), with the supernatant transferred to new centrifuge tubes after each spin
